[ 123 I]iomazenil (IMZ) is a specific radioligand for the central benzodiazepine (BZ) receptor that may be useful as a marker of cortical neuron loss after cerebral ischemia using single photon emission computed tomography (SPECT). This study used statistical imaging analysis for IMZ-SPECT to investigate the relationship between higher brain dysfunction and cortical neuron loss in the medial frontal lobes, to establish a confirmatory diagnosis of higher brain dysfunction in patients with adult moyamoya disease. IMZ-SPECT was estimated by three-dimensional stereotactic surface projections (3D-SSP). Cortical neuron loss was analyzed using the stereotactic extraction estimation (SEE) method (level 3: gyrus level) for 3D-SSP Z-score maps (Z-score À2). Extent of pixels with significant reduction of BZ receptor density within the target gyri (i.e. bilateral medial frontal gyri [MFGs] and anterior cingulate gyri [ACGs]) was calculated. In 6 patients with higher brain dysfunction, significant cortical neuron loss was observed in the bilateral MFGs in 4 patients, unilateral MFG in 1 patient, and bilateral ACGs in 2 patients. In 12 patients without higher brain dysfunction, no significant cortical neuron loss was observed in the bilateral MFGs or ACGs, and mild loss was observed in the bilateral MFGs in 2 patients, unilateral MFG in 4 patients, and unilateral ACG in 2 patients. Long-standing mild hemodynamic ischemia in the anterior circulation of patients with adult moyamoya disease could lead to incomplete brain infarction within the medial frontal lobes. Statistical imaging analysis using 3D-SSP and SEE methods for IMZ-SPECT could demonstrate significant cortical neuron loss in the bilateral frontal medial cortices involving MFG and/or ACG which correlate with higher brain dysfunction in patients with adult moyamoya disease.
Introduction
Patients with adult moyamoya disease may suffer higher brain dysfunction 18) manifesting as cognitive impairments, such as memory, attention, performance, and social behavioral disturbances, which could become increasingly apparent. 8) Such cognitive impairments may occur in patients with medial frontal lobe damage including the anterior cingulate cortex. 1, 19) In general, higher brain dysfunction associated with adult moyamoya disease could be detected by both neuropsychological findings and obvious medial frontal lobe damage visible on morphological neuroimaging such as computed tomography (CT) or magnetic resonance (MR) imaging. These patients should be supported by social welfare as psychologically handicapped persons. However, confirmatory diagnosis of higher brain dysfunction in patients with adult moyamoya disease without obvious medial frontal lobe damages on CT or MR imaging has not been established and could become a social 4, 17) could be estimated by functional neuroimaging using single photon emission CT (SPECT), because central benzodiazepine (BZ) receptor mapping using [ 123 I]iomazenil (IMZ) 2) is available for clinical use. IMZ is a specific radioactive tracer for the central BZ receptor that may be useful as a marker of cortical neuron loss after focal cerebral ischemia using SPECT. 7, 17) This study used statistical imaging analysis for IMZ-SPECT to investigate the relationship between higher brain dysfunction and the occurrence of incomplete brain infarction in the medial frontal lobes to establish confirmatory diagnosis of higher brain dysfunction in patients with adult moyamoya disease. 15) 
Materials and Methods
Eighteen patients with adult moyamoya disease (3 males and 15 females with mean age of 39.3 ± 9.0 years) in the chronic stage were included in this study (Table 1 ). All patients had a clinical history of transient ischemic attack (TIA) or stroke episodes, and type of brain attack was classified as TIA, ischemic stroke, intraventricular hemorrhage (IVH), or intracerebral hemorrhage (ICH). Surgical revascularization was performed in 16 of the 18 patients, and long-term follow up was possible in all patients ( Table 1 ). The outcome of TIA or other stroke in these patients was assessed by modified Rankin scale as 0-2, and daily life was independent at the time of study inclusion. Size of cortical infarction, subcortical white matter infarction, or brain injury associated with IVH or ICH in these patients was relatively small, and bilateral frontal brain atrophy was very mild on MR imaging in the 3 patients with higher brain dysfunction ( Table 1) . Hemodynamic cerebral ischemia was assessed by the dual table ARG method, 9) and territories of Stage 2 ischemia were not dominant in the anterior circulation, espe- ana'' letter pick-up test), and behavioural assessment of the dysexecutive syndrome (BADS) test. Higher brain dysfunction was defined by combined assessment of neuropsychological tests using the following criteria: lower scores than normal in the WAIS-III test, or lower scores than standard on attention (concentration) or delayed reproduction in the WMS-R test, or marked deviation to each standard on 4 categories in the frontal lobe function test, or lower standardized scores than normal in the BADS test (Table 2) .
Focal reduction of BZ receptor density indicated as decreased IMZ distribution could be a marker of cortical neuron loss. Projection data of IMZ-SPECT were obtained 3 hours after intravenous tracer injection, and IMZ 3-hour images equivalent to the distribution of BZ receptor density were reconstructed. 10) The IMZ 3-hour image could be estimated by statistical imaging analysis such as three-dimensional stereotactic surface projections (3D-SSP). 11) In this analysis, relative IMZ distribution of the cortex on 3D-SSP was compared with the normal database (n ＝ 18), in which all pixels have both mean count value and standard deviation normalized by count value of reference regions such as global brain. Differences between individual data and the normal database in each pixel were converted to Z-score (multiple of standard deviation), then the cluster of pixels with significant difference (Z-score À2) could be identified as the target area with cortical neuron loss on Z-score maps (total 8 directions).
For assessment of cortical neuron loss in the frontal lobes, areas of cortical neuron loss around the medial frontal gyrus (MFG) and anterior cingulate gyrus (ACG) on Z-score maps were focused within the medial frontal lobe, and such areas around the superior frontal gyrus and middle frontal gyrus on Z-score maps were focused within the lateral frontal lobe by visual assessment (Tables 1 and 2 ). Clusters of pixels on Z-score maps (Z score À2) were defined as significant cortical neuron loss, and assessed as follows: ＋ ＋, cortical neuron loss in multiple areas; ＋, cortical neuron loss in single area; and -, no area of cortical neuron loss. Group comparison was performed between the normal database and 2 patient groups (6 patients with higher brain dysfunction and 12 patients without higher brain dysfunc- For assessment of cortical neuron loss in the frontal medial cortex, cortical neuron loss was analyzed using the stereotactic extraction estimation (SEE) method (level 3: gyrus level analysis) 12, 13) for Z-score maps (Z-score À2). Extent (%) of pixels with significant reduction of BZ receptor density within the target gyri (i.e. bilateral MFGs and ACGs) was calculated on Z-score maps (Tables 1 and 2) . Extent of such pixels À10% in the target gyri was defined as significant cortical neuron loss, and º10% to À1% in the target gyri was defined as mild cortical neuron loss, based on a scattering ratio (%) of the normal database.
Results
Areas of cortical neuron loss in the medial frontal lobes were observed bilaterally in all 6 patients with higher brain dysfunction, but not bilaterally in all 12 patients without higher brain dysfunction (Tables 3  and 4 ). In contrast, areas of cortical neuron loss in the lateral frontal lobes were observed bilaterally in 2 and unilaterally in 3 of 6 patients with higher brain dysfunction, and bilaterally in 1 and unilaterally in 4 Fig. 1 Group comparison between the normal database and 6 patients with higher brain dysfunction (Z-score À2). Upper row: standardized brain surface (8 directions) on magnetic resonance images (MRI), 2nd row: Z-score images using normalized counts of the global brain (GLB), 3rd row: Z-score images using normalized counts of the thalamus (THL), 4th row: Z-score images using normalized counts of the cerebellum (CBL), 5th row: Z-score images using normalized counts of the pons (PNS). Color in the right bar shows clusters of pixels (Z-score À2). The Z-score images (2nd row) show common areas of significant cortical neuron loss in the bilateral medial frontal lobes, especially around the bilateral medial frontal gyri. Fig. 2 Group comparison between the normal database and 12 patients without higher brain dysfunction (Z-score À2). Upper row: standardized brain surface (8 directions) on magnetic resonance images (MRI), 2nd row: Z-score images using normalized counts of the global brain (GLB), 3rd row: Z-score images using normalized counts of the thalamus (THL), 4th row: Z-score images using normalized counts of the cerebellum (CBL), 5th row: Z-score images using normalized counts of the pons (PNS). Color in the right bar shows clusters of pixels (Z-score À2). The Z-score images (2nd row) show no common areas of significant cortical neuron loss in the bilateral medial frontal lobes. (Tables 3 and 4) . Group comparison between the normal database and 6 patients with higher brain dysfunction demonstrated common target areas of significant cortical neuron loss in the bilateral medial frontal lobes, especially around the bilateral MFGs (Fig. 1) . In contrast, group comparison between the normal database and 12 patients without higher brain dysfunction demonstrated no common target areas of significant cortical neuron loss in the bilateral medial frontal lobes (Fig. 2) .
Assessment of significant neuron loss in the bilateral frontal medial cortices was mainly performed in patients with higher brain dysfunction. Significant neuron loss was observed in the bilateral MFGs in 4 patients (67%) and the unilateral MFG in 1 patient (17%), and mild neuron loss was observed in the bilateral MFGs in 1 patient (17%) (Table 3, Fig.  3 ). Mean extent of abnormal pixels which indicated reduction of BZ receptor was 22.3 ± 15.5% in the left MFG, and 20.3 ± 11.2% in the right MFG (Table  3 ). Significant cortical neuron loss was observed in the bilateral ACGs in 2 patients (33%), and mild cortical neuron loss was observed in the bilateral ACGs in 2 patients (33%) (Fig. 3) . Mean extent of abnormal pixels which indicated reduction of BZ receptor was 8.5 ± 9.6% in the left ACG, and 13.2 ± 17.0% in the right ACG (Table 3 ). In 6 patients with higher brain dysfunction, significant or mild cortical neuron loss in the bilateral MFGs was more frequent than in the bilateral ACGs (Table 3 ). In the 12 patients without higher brain dysfunction, mild cortical neuron loss was observed in the bilateral MFGs in 2 patients (17%), unilateral MFG in 4 patients (33%), and unilateral ACG in only 2 patients (17%) ( Table 4 , Fig.  4 ).
Discussion
IMZ is a specific radioligand for the central BZ receptor that could be useful to provide a marker of cortical neuron loss after focal cerebral ischemia. 7, 17) The reduction of BZ receptor density in reperfused cortex that remained structurally intact is likely to be the result of injury to only a limited number of neurons (i.e., incomplete brain infarction). 4, 17) The study of permanent or transient ischemia (lasting 3 to 6 hours) in baboons using [ 18 F]flumazenil as a BZ 20) has a more direct relevance to study incomplete brain infarction in reperfused cortex using IMZ-SPECT. The study observed decreased BZ receptor binding not only in the infarcted area (to a great degree) but also in the CT-intact opercular cortex overlying the hypodense area (to a lesser degree). Selective neuronal necrosis with sparing of glia and microvessels is seen after transient occlusion of the middle cerebral artery in macaque monkey and rats. 3, 5) The extent of ischemic neuronal damage depends on both the magnitude and duration of cerebral ischemia. In another study, up to 60 minutes of middle cerebral artery occlusion followed by 7 days of survival in rats resulted in neuronal necrosis that involved isolated groups of cortical neurons (i.e., incomplete brain infarction), but no cases of cortical infarction. 6) A close correlation existed between the number of necrotic neurons and the severity of the neurological deficits. Incomplete brain infarction defined by the reduction of central BZ receptor density using IMZ-SPECT had been observed within ischemic penumbra salvaged by restored cerebral blood flow in acute stroke, 4) and could occur within hemodynamic cerebral ischemia such as misery perfusion in chronic stroke. 15) In the present study, the relationship between long-term mild hemodynamic ischemia and the occurrence of incomplete brain infarction in the bilateral medial frontal lobes was estimated by IMZ-SPECT in patients with adult moyamoya disease to establish confirmatory diagnosis of higher brain dysfunction. Our study observed significant cortical neuron loss in the bilateral medial frontal lobes involving MFG and/or ACG in 6 patients with higher brain dysfunction defined by neuropsychological tests (Table 3) . Group comparison between 6 patients with higher brain dysfunction and the normal database found significant cortical neuron loss in the bilateral medial frontal lobes involving MFG (Fig. 1) . On the other hand, none of the 12 patients without higher brain dysfunctions had significant cortical neuron loss in the bilateral medial frontal lobes involving MFG and/or ACG (Table 4) . Group comparison between 12 patients without higher brain dysfunction and the normal database found no significant cortical neuron loss in the bilateral medial frontal lobes (Fig. 2) . These findings suggest that incomplete brain infarction due to long-term mild hemodynamic ischemia could occasionally occur in the bilateral medial frontal lobes involving MFG and/or ACG, and may correlate with higher brain dysfunction in patients with adult moyamoya disease. Recently, an IMZ-SPECT study also demonstrated areas of cortical neuron loss in the bilateral medial frontal lobes involving MFG and/or ACG in patients with higher brain dysfunction after mild traumatic brain injury. 16) Cortical neuron loss in the bilateral medial frontal lobes involving MFG and/or ACG could be an essential finding for the confirmatory diagnosis of higher brain dysfunction.
Statistical imaging analysis using 3D-SSP (Z-score maps) for IMZ-SPECT could provide accurate visual information on cortical neuron loss in the medial frontal lobes. Additionally, the SEE method (level 3: gyrus level analysis) could be useful to estimate cortical neuron loss in the target gyri (i.e. bilateral MFGs and ACGs) which correlate with higher brain dysfunction. In the present study, cortical neuron loss in the target gyri was defined by extent (%) of pixels with significant reduction of BZ receptor density À10% based on a scattering ratio of the normal database, but how the extent (%) of pixels with significant reduction of BZ receptor density within the target gyri correlates with higher brain dysfunction remains unclear. A multicenter study should be performed to confirm the standard criteria for diagnostic imaging of higher brain dysfunction using IMZ-SPECT.
Lastly, some limitations in this pilot study should be emphasized for designing any future study. The first limitation is the study bias on patient selection due to the single center study. The battery of neuropsychological tests and diagnostic criteria for patients with higher brain dysfunction should be standardized. The second limitation is the possibility of improper management of SPECT image data. Independent section for study data management should perform an audit of all data involving SPECT images. The third limitation is the unreliability of statistical group comparison due to the small number of registered patients. The fourth limitation is the insufficiency of standardized criteria for imaging analysis using the SEE method. The fifth limitation is the absence of verification by other functional imaging modality such as PET. These study limitations should be overcome by a large multicenter study.
In conclusion, long-standing mild hemodynamic ischemia in the anterior circulation of patients with adult moyamoya disease could lead to incomplete brain infarction (selective loss of cortical neurons) defined by reduction of central BZ receptor density within the medial frontal lobes. Statistical imaging analysis using 3D-SSP and SEE methods for IMZ-SPECT could demonstrate significant cortical neuron loss in the bilateral frontal medial cortices involving MFG and/or ACG which correlate with higher brain dysfunction in patients with adult moyamoya disease. A multicenter study should be performed to establish confirmatory diagnosis of higher brain dysfunction in patients with adult moyamoya disease using IMZ-SPECT.
